Skip to main content
CME Assistant

Course info

Conferences and Meetings 2026 Highlights of ASH in North America (DC)

2026 Highlights of ASH in North America (DC)

Category: Conferences and Meetings
Short name: 2026 Highlights of ASH in North America (DC)
Course start date: 01/12/2026
Course end date: 01/13/2026
Enroll me

Sections

General
0 activities

Instructions To claim CME credits or recognition o...
To claim CME credit and download your CME certific... (copy)
Demographics and Overall Survey
Thank you for taking part in a Highlights of ASH e...
Friday Sessions
Plasma Cell Disorder Personalization: How I Risk Stratify Patients and Sequence Therapies in Myeloma, AL Amyloidosis, and Their Precursors
Participation Credit for Plasma Cell Disorder Personalization: How I Risk Stratify Patients and Sequence Therapies in Myeloma, AL Amyloidosis, and Their Precursors
CME Credit for Plasma Cell Disorder Personalization: How I Risk Stratify Patients and Sequence Therapies in Myeloma, AL Amyloidosis, and Their Precursors
MOC Credit for Plasma Cell Disorder Personalization: How I Risk Stratify Patients and Sequence Therapies in Myeloma, AL Amyloidosis, and Their Precursors
Best of ASH in Allogeneic Transplantation: Innovations in Donor Selection, GVHD Prophylaxis, MRD-Guided Strategies, and Transplant Care
Participation Credit for Best of ASH in Allogeneic Transplantation: Innovations in Donor Selection, GVHD Prophylaxis, MRD-Guided Strategies, and Transplant Care
CME Credit for Best of ASH in Allogeneic Transplantation: Innovations in Donor Selection, GVHD Prophylaxis, MRD-Guided Strategies, and Transplant Care
MOC Credit for Best of ASH in Allogeneic Transplantation: Innovations in Donor Selection, GVHD Prophylaxis, MRD-Guided Strategies, and Transplant Care
Advances in Pediatric Hematologic Malignancies: From Enhanced Risk Stratification to Novel Therapies
Participation Credit for Advances in Pediatric Hematologic Malignancies: From Enhanced Risk Stratification to Novel Therapies
CME Credit for Advances in Pediatric Hematologic Malignancies: From Enhanced Risk Stratification to Novel Therapies
MOC Credit for Advances in Pediatric Hematologic Malignancies: From Enhanced Risk Stratification to Novel Therapies
Panel Discussion I
Participation Credit for Panel Discussion I
CME Credit for Panel Discussion I
MOC Credit for Panel Discussion I
Advances in Aggressive Lymphoma in the Novel Therapy Era
Participation Credit for Advances in Aggressive Lymphoma in the Novel Therapy Era
CME Credit for Advances in Aggressive Lymphoma in the Novel Therapy Era
MOC Credit for Advances in Aggressive Lymphoma in the Novel Therapy Era
How I Treat Acute Lymphoblastic Leukemia in 2026: Sequencing for Cure in the Era of Targeted and Novel Immune Therapies
Participation Credit for How I Treat Acute Lymphoblastic Leukemia in 2026: Sequencing for Cure in the Era of Targeted and Novel Immune Therapies
CME Credit for How I Treat Acute Lymphoblastic Leukemia in 2026: Sequencing for Cure in the Era of Targeted and Novel Immune Therapies
MOC Credit for How I Treat Acute Lymphoblastic Leukemia in 2026: Sequencing for Cure in the Era of Targeted and Novel Immune Therapies
Advances in Chronic Lymphocytic Leukemia and Indolent B-Cell Lymphomas
Participation Credit for Advances in Chronic Lymphocytic Leukemia and Indolent B-Cell Lymphomas
CME Credit for Advances in Chronic Lymphocytic Leukemia and Indolent B-Cell Lymphomas
MOC Credit for Advances in Chronic Lymphocytic Leukemia and Indolent B-Cell Lymphomas
Panel Discussion II
Participation Credit for Panel Discussion II
CME Credit for Panel Discussion II
MOC Credit for Panel Discussion II
Saturday Sessions
Frontiers in Bleeding Disorder Care: Novel Therapies and Clinical Practice
Participation Credit for Frontiers in Bleeding Disorder Care: Novel Therapies and Clinical Practice
CME Credit for Frontiers in Bleeding Disorder Care: Novel Therapies and Clinical Practice
MOC Credit for Frontiers in Bleeding Disorder Care: Novel Therapies and Clinical Practice
Advances in Thrombosis and Hemostasis: From Cancer-Associated VTE to Precision Risk Prediction
Participation Credit for Advances in Thrombosis and Hemostasis: From Cancer-Associated VTE to Precision Risk Prediction
CME Credit for Advances in Thrombosis and Hemostasis: From Cancer-Associated VTE to Precision Risk Prediction
MOC Credit for Advances in Thrombosis and Hemostasis: From Cancer-Associated VTE to Precision Risk Prediction
Hematology Through a Gender Lens: Evolving Insights into Unique and Underrecognized Challenges in Hematology
Participation Credit for Hematology Through a Gender Lens: Evolving Insights into Unique and Underrecognized Challenges in Hematology
CME Credit for Hematology Through a Gender Lens: Evolving Insights into Unique and Underrecognized Challenges in Hematology
MOC Credit for Hematology Through a Gender Lens: Evolving Insights into Unique and Underrecognized Challenges in Hematology
Panel Discussion III
Participation Credit for Panel Discussion III
CME Credit for Panel Discussion III
MOC Credit for Panel Discussion III
Progress and Promise: Translating Innovation into Clinical Practice for MDS, MPN, and CML
Participation Credit for Progress and Promise: Translating Innovation into Clinical Practice for MDS, MPN, and CML
CME Credit for Progress and Promise: Translating Innovation into Clinical Practice for MDS, MPN, and CML
MOC Credit for Progress and Promise: Translating Innovation into Clinical Practice for MDS, MPN, and CML
The Future is Now: Advances in Acute Myeloid Leukemia
Participation Credit for The Future is Now: Advances in Acute Myeloid Leukemia
CME Credit for The Future is Now: Advances in Acute Myeloid Leukemia
MOC Credit for The Future is Now: Advances in Acute Myeloid Leukemia
Panel Discussion IV
Participation Credit for Panel Discussion IV
CME Credit for Panel Discussion IV
MOC Credit for Panel Discussion IV
Novel Therapies and Clinical Outcomes in Hemoglobinopathies
Participation Credit for Novel Therapies and Clinical Outcomes in Hemoglobinopathies
CME Credit for Novel Therapies and Clinical Outcomes in Hemoglobinopathies
MOC Credit for Novel Therapies and Clinical Outcomes in Hemoglobinopathies
Immune Cytopenias: Targeted, Tailored, Transformed
Participation Credit for Immune Cytopenias: Targeted, Tailored, Transformed
CME Credit for Immune Cytopenias: Targeted, Tailored, Transformed
MOC Credit for Immune Cytopenias: Targeted, Tailored, Transformed
Artificial Intelligence & Informatics in Hematology: Driving Practice Improvement and Patient-Centered Care
Participation Credit for Artificial Intelligence & Informatics in Hematology: Driving Practice Improvement and Patient-Centered Care
CME Credit for Artificial Intelligence & Informatics in Hematology: Driving Practice Improvement and Patient-Centered Care
MOC Credit for Artificial Intelligence & Informatics in Hematology: Driving Practice Improvement and Patient-Centered Care
Panel Discussion V
Participation Credit for Panel Discussion V
CME Credit for Panel Discussion V
MOC Credit for Panel Discussion V
Please complete the Demographic & Overall Survey a...
Download Certificate of Completion
Download CME Certificate
If you are an ABIM certificant and wish to claim A...
ABIM MOC Reflective Statement
You have done everything necessary to claim ABIM M...
Your reflective statement for ABIM/MOC Medical Kno...
View ABIM MOC Submission
Text and media area Text and media area
9
Questionnaire Questionnaire
20
Credit activity Credit activity
57
Certificate Certificate
2
Assignment Assignment
1
PARS activity PARS activity
1
Enroll me
Accreditation
Accredited
Learning Format
Live
Location
Washington, D.C.
Activity date(s)
12 January 2026

Instructors

CME Assistant CME Assistant